Cancer Screening and Cancer Treatment in Kidney Transplant Recipients
Main Author: | |
---|---|
Publication Date: | 2024 |
Other Authors: | , , |
Format: | Other |
Language: | eng |
Source: | Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
Download full: | http://hdl.handle.net/10362/175182 |
Summary: | Publisher Copyright: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology. |
id |
RCAP_315f89b46c3f9bd8fcfdf1d8f6663b50 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/175182 |
network_acronym_str |
RCAP |
network_name_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository_id_str |
https://opendoar.ac.uk/repository/7160 |
spelling |
Cancer Screening and Cancer Treatment in Kidney Transplant RecipientsMedicine(all)SDG 3 - Good Health and Well-beingPublisher Copyright: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology.As the population ages and post-transplant survival improves, pretransplant and post-transplant malignancy are becoming increasingly common. In addition, rapid advances in cancer therapies and improving outcomes prompt us to rethink pretransplant cancer-free wait time and screening strategies. Although kidney transplant recipients (KTRs) are at higher risk of developing cancer, epidemiological data on how to best screen and treat cancers in KTRs are incomplete. Thus, current recommendations are still largely on the basis of studies in the general population, and their validity in KTRs is uncertain. Kidney transplant candidates without prior cancer should be evaluated for latent malignancies even in the absence of symptoms. Conversely, individuals with a history of malignancy require thorough monitoring to detect potential recurrences or de novo malignancies. When treating KTRs with cancer, reducing immunosuppression can enhance antitumor immunity, yet this also increases the risk of graft rejection. Optimal treatment and immunosuppression management remains undefined. As the emergence of novel cancer therapies adds complexity to this challenge, individualized risk-benefit assessment is crucial. In this review, we discuss up-to-date data on pretransplant screening and cancer-free wait time, as well as post-transplant cancer screening, prevention strategies, and treatment, including novel therapies such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNBigotte Vieira, MiguelArai, HiroyukiNicolau, Carla Adriana FerreiraMurakami, Naoka2024-11-13T23:52:25Z2024-10-012024-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/other15application/pdfhttp://hdl.handle.net/10362/175182eng2641-7650PURE: 102888124https://doi.org/10.34067/KID.0000000000000545info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-10T01:36:54Zoai:run.unl.pt:10362/175182Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:14:11.747033Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse |
dc.title.none.fl_str_mv |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
title |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
spellingShingle |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients Bigotte Vieira, Miguel Medicine(all) SDG 3 - Good Health and Well-being |
title_short |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
title_full |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
title_fullStr |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
title_full_unstemmed |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
title_sort |
Cancer Screening and Cancer Treatment in Kidney Transplant Recipients |
author |
Bigotte Vieira, Miguel |
author_facet |
Bigotte Vieira, Miguel Arai, Hiroyuki Nicolau, Carla Adriana Ferreira Murakami, Naoka |
author_role |
author |
author2 |
Arai, Hiroyuki Nicolau, Carla Adriana Ferreira Murakami, Naoka |
author2_role |
author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) RUN |
dc.contributor.author.fl_str_mv |
Bigotte Vieira, Miguel Arai, Hiroyuki Nicolau, Carla Adriana Ferreira Murakami, Naoka |
dc.subject.por.fl_str_mv |
Medicine(all) SDG 3 - Good Health and Well-being |
topic |
Medicine(all) SDG 3 - Good Health and Well-being |
description |
Publisher Copyright: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-11-13T23:52:25Z 2024-10-01 2024-10-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/other |
format |
other |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/175182 |
url |
http://hdl.handle.net/10362/175182 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2641-7650 PURE: 102888124 https://doi.org/10.34067/KID.0000000000000545 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
15 application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia instacron:RCAAP |
instname_str |
FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
collection |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) |
repository.name.fl_str_mv |
Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia |
repository.mail.fl_str_mv |
info@rcaap.pt |
_version_ |
1833597962023862272 |